Clinical Evaluation of Lapatinib Administered With Capecitabine in Japanese Patients With ErbB2 Overexpressing Advanced or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2018
At a glance
- Drugs Capecitabine; Lapatinib
- Indications Advanced breast cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 25 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.